Skip to main content

Day: August 31, 2022

MT Højgaard Holding A/S: MT Højgaard Danmark and N.V. BESIX S.A. awarded conditional DKK 2.6 bn contract for construction of the Nordhavn tunnel

MT Højgaard Holding’s business unit MT Højgaard Danmark and Belgian joint venture partner N.V. BESIX S.A. have entered a conditional contract with the Danish Road Directorate for the construction of the Nordhavn tunnel in Copenhagen. The contract value is DKK 2,585 million, and signing is expected after expiration of the standstill period in mid-September 2022. Planning and construction of the building site by Svanemøllen bay will commence immediately after signing of the contract. The joint venture partners N.V. BESIX S.A. and MT Højgaard Danmark will collaborate closely with suppliers Niras, Bravida Danmark and Jacobs Sverige AB for the construction of the Nordhavn tunnel, which is to be commissioned in 2027 and ensure more direct access to the developing areas in the outer and inner Nordhavn. The tunnel will connect Østerbro with outer...

Continue reading

Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)

SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following:More frequent meetings or written communication with the FDA to discuss the SP-103 development plan and ensure collection of appropriate data needed to support drug approval.Eligibility for Accelerated Approval or Priority Review, if relevant criteria are met.Rolling Review, which means that Scilex can submit completed sections of its New Drug Application (NDA) for review by the FDA, rather than waiting until every section of the NDA is completed before the entire application can be reviewed.Despite an overall lack of evidence to support their efficacy, opioids continue to be prescribed to treat acute LBP when patients seek medical evaluation. According to the CDC in 2020, LBP was the most common type of pain reported by patients,...

Continue reading

UPDATE — Privia Health Reports Results in CMS’ Medicare Shared Savings Program

2021 Performance Across All Markets Demonstrates Improved Care and Lower Costs Privia ACOs Delivered Total Annual Average Expenditures 15% Lower than Median MSSP ACO and 24% Lower than Total Fee for Service Medicare $99.9 Million in Shared Savings Delivered across Georgia, Maryland, Texas, Virginia and Washington, DC ARLINGTON, Va., Aug. 30, 2022 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (“ACOs”) delivered quality care and improved patient outcomes, and achieved shared savings of $99.9 million through the Medicare Shared Savings Program (“MSSP”). Privia’s ACOs (collectively “Privia Quality Network”) provided high-value, cost-efficient care to more than 112,000 Medicare beneficiaries in 2021. “Navigating care options for patients during the coronavirus pandemic...

Continue reading

XR Immersive Tech Announces Record Second Quarter Revenue & Corporate Update

VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) — XR Immersive Tech Inc. (“XRi” or “Immersive Tech”, or the “Company”) (CSE:VRAR) (FSE:79W) (OTCQB: FNTTF) a leading location-based virtual reality (“LBVR”) content distribution and facility management platform, today announced results for its second quarter and first half of its fiscal 2022 year ended June 30, 2022 as well as providing a mid-year corporate update. “We had a great second quarter, and first half of 2022, with revenues climbing sharply including a number of strategic key milestones reached which I am excited to share,” said Tim Bieber XRi CEO. XRi delivered the following results for its second quarter and first half of its fiscal 2022 year: In the Company’s second quarter revenue was $348,328 with associated cost of goods sold of $71,375, a revenue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.